Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Overview: Japanese guidelines for myocardial revascularization to treat stable ischemic heart disease 2012.

Ochi M.

Gen Thorac Cardiovasc Surg. 2013 May;61(5):246-53. doi: 10.1007/s11748-012-0182-4. Epub 2012 Dec 12.

PMID:
23232903
2.

Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.

Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE.

JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718. Review.

PMID:
24240936
3.

Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).

Pandey A, McGuire DK, de Lemos JA, Das SR, Berry JD, Brilakis ES, Banerjee S, Marso SP, Barsness GW, Simon DN, Roe M, Goyal A, Kosiborod M, Amsterdam EA, Kumbhani DJ.

Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.

4.

Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.

Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Ohishi M, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Imoto Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ Cardiovasc Interv. 2014 Aug;7(4):482-91. doi: 10.1161/CIRCINTERVENTIONS.113.001056. Epub 2014 Jul 29.

5.

PCI versus CABG versus medical therapy in 2006.

Morrison D.

Minerva Cardioangiol. 2006 Oct;54(5):643-72. Review.

PMID:
17019400
6.

Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.

Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW.

Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.

PMID:
24849105
7.
8.

Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.

Marui A, Kimura T, Nishiwaki N, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Eur J Cardiothorac Surg. 2015 Feb;47(2):316-21; discussion 321. doi: 10.1093/ejcts/ezu131. Epub 2014 Mar 23.

PMID:
24662243
9.

Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy.

Buszman P, Szkróbka I, Gruszka A, Parma R, Tendera Z, Leśko B, Wilczyński M, Bochenek T, Wojakowski W, Bochenek A, Tendera M.

Am J Cardiol. 2007 Jan 1;99(1):36-41. Epub 2006 Nov 3.

PMID:
17196458
10.

Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.

Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W; European Society of Cardiology.

Eur Heart J. 2005 Jun;26(12):1169-79. Epub 2005 Mar 31.

PMID:
15802360
12.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2014 Aug 15;114(4):555-61. doi: 10.1016/j.amjcard.2014.05.034. Epub 2014 Jun 6.

PMID:
24996550
13.

Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.

Kim LJ, King SB 3rd, Kent K, Brooks MM, Kip KE, Abbott JD, Jacobs AK, Rihal C, Hueb WA, Alderman E, Sing IR, Attubato MJ, Feit F; BARI 2D (Bypass Angioplasty Revascularization Investigation Type 2 Diabetes) Study Group.

JACC Cardiovasc Interv. 2009 May;2(5):384-92. doi: 10.1016/j.jcin.2009.01.009.

14.

[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].

Yang BG, Yu XP, Chen F, Lyu SZ, Li Q, He JQ, Yuan F.

Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005. Chinese.

PMID:
28100341
15.

Cost-effectiveness of revascularization strategies: the ASCERT study.

Zhang Z, Kolm P, Grau-Sepulveda MV, Ponirakis A, O'Brien SM, Klein LW, Shaw RE, McKay C, Shahian DM, Grover FL, Mayer JE, Garratt KN, Hlatky M, Edwards FH, Weintraub WS.

J Am Coll Cardiol. 2015 Jan 6;65(1):1-11. doi: 10.1016/j.jacc.2014.09.078.

16.

The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.

Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.

PMID:
19797974
17.

Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.

Cho Y, Misumi T, Shimura S, Aki A, Furuya H, Odagiri S, Okada K, Ueda T.

Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.

PMID:
23979988
18.

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.

Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW; SYNTAX Trial Investigators.

Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.

19.

Improved long-term survival for diabetic patients with surgical versus interventional revascularization.

Kurlansky P, Herbert M, Prince S, Mack MJ.

Ann Thorac Surg. 2015 Apr;99(4):1298-305. doi: 10.1016/j.athoracsur.2014.11.035. Epub 2015 Feb 14.

PMID:
25686668
20.

Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.

Burgess SN, Mussap CJ, French JK.

Clin Ther. 2013 Aug;35(8):1069-75. doi: 10.1016/j.clinthera.2013.07.427. Review.

PMID:
23973040

Supplemental Content

Support Center